Published in J Acquir Immune Defic Syndr on March 01, 2009
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc (2013) 2.06
Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol (2013) 2.01
Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS (2010) 1.83
Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci U S A (2009) 1.79
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71
Measures of frailty in population-based studies: an overview. BMC Geriatr (2013) 1.69
Early immune senescence in HIV disease. Curr HIV/AIDS Rep (2010) 1.58
Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr (2012) 1.58
Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis (2013) 1.49
A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci (2011) 1.36
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis. AIDS (2013) 1.31
Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr (2013) 1.23
A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc (2012) 1.22
Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci (2013) 1.19
Frailty syndrome: an overview. Clin Interv Aging (2014) 1.11
Inflammation and immune system alterations in frailty. Clin Geriatr Med (2011) 1.04
Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int (2010) 1.03
Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr (2013) 0.99
Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc (2014) 0.97
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci (2011) 0.96
Frailty, inflammation, and immunity. Aging Dis (2011) 0.93
Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep (2014) 0.91
An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr (2014) 0.88
Immunologic changes in frail older adults. Transl Med UniSa (2014) 0.87
Premature expression of a muscle fibrosis axis in chronic HIV infection. Skelet Muscle (2012) 0.86
Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res Ther (2012) 0.84
Relationship of physical function and quality of life among persons aging with HIV infection. AIDS (2014) 0.81
RNA surveillance-an emerging role for RNA regulatory networks in aging. Ageing Res Rev (2010) 0.81
Heterogeneity of CD4+ and CD8+ T-cell responses to cytomegalovirus in HIV-infected and HIV-uninfected men who have sex with men. J Infect Dis (2014) 0.81
Measuring frailty in HIV-infected individuals. Identification of frail patients is the first step to amelioration and reversal of frailty. J Vis Exp (2013) 0.81
Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep (2015) 0.80
Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy. J Womens Health (Larchmt) (2013) 0.80
HIV, aging, and advance care planning: are we successfully planning for the future? J Palliat Med (2012) 0.80
Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment. PLoS One (2014) 0.78
FUNCTIONAL LIMITATIONS AND ADIPOKINES IN HIV-INFECTED OLDER ADULTS. J Frailty Aging (2015) 0.76
Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women - The Women's Interagency HIV Study. J Frailty Aging (2016) 0.76
Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults. J Virol (2014) 0.76
High perceived social standing is associated with better health in HIV-infected Ugandan adults on highly active antiretroviral therapy. J Behav Med (2016) 0.76
Ocular parameters of biological ageing in HIV-infected individuals in South Africa: relationship with chronological age and systemic biomarkers of ageing. Mech Ageing Dev (2013) 0.75
Enhancing physical function in HIV-infected older adults: A randomized controlled clinical trial. Health Psychol (2016) 0.75
Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs. Curr HIV/AIDS Rep (2016) 0.75
p16(INK4a) , a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected Subjects. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
FRAILTY, FOOD INSECURITY, AND NUTRITIONAL STATUS IN PEOPLE LIVING WITH HIV. J Frailty Aging (2015) 0.75
Sexual behaviors and results of bacterial sexually transmitted infections testing among frail HIV-infected individuals. J Int Assoc Physicians AIDS Care (Chic) (2010) 0.75
Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study. Open Med J (2016) 0.75
Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review. Trop Med Int Health (2017) 0.75
Faces of Frailty in Aging with HIV Infection. Curr HIV/AIDS Rep (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care (1994) 19.87
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol (1999) 8.60
Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00
Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81
Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med (2000) 5.34
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol (2008) 4.25
Infection with HIV is associated with elevated IL-6 levels and production. J Immunol (1990) 3.89
The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol (1995) 3.54
HIV disease and the endocrine system. N Engl J Med (1992) 3.48
Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med (1995) 3.46
Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc (2005) 3.29
Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc (2002) 3.21
Unstable disability and the fluctuations of frailty. Age Ageing (1997) 3.03
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS (1996) 2.95
Human immunosenescence: is it infectious? Immunol Rev (2005) 2.83
The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis (2004) 2.83
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75
Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am (2003) 2.73
Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci (1998) 2.68
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology (2002) 2.68
Inflammation and frailty in older women. J Am Geriatr Soc (2007) 2.66
The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev (2005) 2.62
Ageing, immune response, and mortality. Lancet (1974) 2.43
Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS (2005) 2.42
Accelerated immune senescence and HIV-1 infection. Exp Gerontol (2007) 2.41
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med (2002) 2.36
From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ (2005) 2.19
Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ (2004) 2.14
Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev (1998) 2.12
Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci (2005) 2.08
Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. J Infect Dis (1994) 1.93
Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol (1991) 1.84
Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.79
Ageing of lymphocytes and lymphocytes in the aged. Immunol Today (2000) 1.65
Premature ageing of the immune system: the cause of AIDS? Trends Immunol (2002) 1.55
Frailty and the older man. Med Clin North Am (1999) 1.54
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol (2003) 1.50
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med (2004) 1.47
Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS (2004) 1.45
Frailty--the search for underlying causes. Sci Aging Knowledge Environ (2004) 1.42
Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res (2003) 1.35
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Rev (2005) 1.35
Oxidative stress in human immunodeficiency virus infection. Cell Mol Life Sci (1997) 1.34
Induction of interleukin-6 during human immunodeficiency virus infection. Blood (1990) 1.32
Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.29
Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol (1998) 1.29
Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol Lett (2005) 1.28
Biomarkers of frailty in older persons. J Endocrinol Invest (2002) 1.25
Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
T cell subsets and mortality in older community-dwelling women. Exp Gerontol (2005) 1.10
Psychological effects of HAART: a 2-year study. Psychosom Med (2000) 1.07
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol (2002) 1.07
Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw (2003) 1.04
Frailty of older age: the role of the endocrine--immune interaction. Curr Pharm Des (2006) 1.03
The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr (1994) 1.00
Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, U.S.A. Introduction. Aging (Milano) (1992) 1.00
Lymphocyte count and mortality risk in older persons. The Leiden 85-Plus Study. J Am Geriatr Soc (2003) 0.99
Long-term immunological memory against viruses. Mech Ageing Dev (2000) 0.99
Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology (1996) 0.99
The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci (2005) 0.98
A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Arch Gen Psychiatry (1997) 0.96
A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol (1985) (2007) 0.94
Basic biology and clinical impact of immunosenescence. Exp Gerontol (2002) 0.88
Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol (2005) 0.87
Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol (1993) 0.84
HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages? Clin Infect Dis (2005) 0.83
Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy. Curr Infect Dis Rep (2004) 0.82
Relationship between the immune system and frailty: pathogenesis of immune deficiency in HIV infection and aging. Aging (Milano) (1992) 0.80
Focused review: physiatric management of HIV-related disability. Arch Phys Med Rehabil (1996) 0.77
Diagnosis and treatment of endocrine disorders in the HIV-infected patient. J Int Assoc Physicians AIDS Care (1998) 0.77
CD4+ T-lymphocytopenia in the elderly. Eur J Clin Microbiol Infect Dis (1995) 0.77
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA (2005) 20.53
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med (2003) 9.75
Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00
Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81
Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity (2012) 6.29
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc (2004) 5.80
Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg (2010) 5.72
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60
Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med (2002) 4.97
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol (2003) 4.56
Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36
Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med (2004) 4.06
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05
LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell (2008) 4.02
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88
The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2007) 3.76
The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. J Am Geriatr Soc (2005) 3.73
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc (2004) 3.52
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. J Infect Dis (2007) 3.39
Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc (2003) 3.30
Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc (2005) 3.29
Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med (2014) 3.24
Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc (2002) 3.21
Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol (2004) 3.17
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr (2009) 2.88
Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention. J Am Geriatr Soc (2002) 2.85
The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis (2004) 2.83
Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci (2012) 2.82
Reliability and sensitivity to change assessed for a summary measure of lower body function: results from the Women's Health and Aging Study. J Clin Epidemiol (2002) 2.79
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J Virol (2003) 2.78
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest (2009) 2.75
Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med (2005) 2.74
Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med (2007) 2.71
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr (2002) 2.70
Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis (2007) 2.67
Inflammation and frailty in older women. J Am Geriatr Soc (2007) 2.66
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol (2013) 2.64
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2005) 2.59
Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59
Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS (2002) 2.57
Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med (2005) 2.52
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol (2008) 2.48
Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS (2005) 2.48
HIV incidence determination in the United States: a multiassay approach. J Infect Dis (2012) 2.47
Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev (2005) 2.45
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2008) 2.44
Treating our societal scotoma: the case for investing in geriatrics, our nation's future, and our patients. Ann Intern Med (2012) 2.44
Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32
Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods (2003) 2.32
Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2005) 2.32
Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol (2007) 2.30
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20
Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet (2003) 2.19
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Virol (2011) 2.18
What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc (2004) 2.18
Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS (2014) 2.18
Dual HIV-1 infection associated with rapid disease progression. Lancet (2004) 2.17
Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis (2013) 2.15
Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2002) 2.13
The association of race with frailty: the cardiovascular health study. Ann Epidemiol (2006) 2.11
Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab (2003) 2.09
Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci (2005) 2.08
Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology (2007) 2.05
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Experience Corps: design of an intergenerational program to boost social capital and promote the health of an aging society. J Urban Health (2004) 2.04